Unitary EPSP were recorded in two identified neurons of the snail ganglia after stimulation of an identified presynaptic neuron. Low-frequency EPSP depression was found in the course of repetitive stimulation (0.1-0.5/s). Transmitter release at two synapses was analyzed in terms of the depletion model using known and modified methods. The fraction of available pool (F) released by a presynaptic impulse was not significantly different at synapses of two different target neurons. The available pool of transmitter (C) and the rate constant of demobilization (k) in the RPa3 neuron were found to be 2-3 times and mobilization (M) 10 times as high as in the LPa2 neuron. Deviations of the depletion model from the experimental data were found. A new method was developed permitting k to be determined and any change in F to be postulated. No significant correlation was found between parameters of the depletion model F and C and the binomial parameters p and n calculated on the basis of the quantal hypothesis, which shows that the depletion model and quantal hypothesis describe different synaptic mechanisms.

Download full-text PDF

Source

Publication Analysis

Top Keywords

depletion model
16
quantal hypothesis
8
depletion
5
[parameters model
4
model transmitter
4
transmitter depletion
4
depletion synapses
4
synapses identified
4
identified snail
4
snail neurons]
4

Similar Publications

Drug Development.

Alzheimers Dement

December 2024

Biogen, Cambridge, MA, USA.

Background: Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by the formation of amyloid-beta (Aβ) plaques and neurofibrillary tangles (NFTs) composed of tau aggregates. Research in animal models has generated hypotheses on the underlying mechanisms of the interaction between Aβ and tau pathology. In support of this interaction, results from clinical trials have shown that treatment with anti-Aβ monoclonal antibodies (mAbs) affects tau pathology.

View Article and Find Full Text PDF

Drug Development.

Alzheimers Dement

December 2024

Department of Bioengineering, University of California, Los Angeles, CA, USA, Los Angeles, CA, USA.

Background: The initiation of amyloid plaque deposition signifies a crucial stage in Alzheimer's disease (AD) progression, which often coincides with the disruption of neural circuits and cognitive decline. While the role of excitatory-inhibitory balance is increasingly recognized in AD pathophysiology, targeted therapies to modulate this balance remain underexplored. This study investigates the effect of perampanel, a selective non-competitive AMPA receptor antagonist, in modulating neurophysiological changes in hAPP-J20 transgenic Alzheimer's mice.

View Article and Find Full Text PDF

Background: Alzheimer's disease neuropathology involves the deposition in brain of aggregates enriched with microtubule-binding-region (MTBR) of tau adopting an abnormal conformation between residues 306-378 in the core of aggregates. Anti-tau drugs targeting around this domain have the potential to interfere with the cell-to-cell propagation of pathological tau. Bepranemab is a humanized monoclonal Ig4 antibody binding to tau residues 235-250.

View Article and Find Full Text PDF

Background: Accumulating evidence suggests that the presynaptic protein α-synuclein (α-syn), is involved in the pathophysiology of AD and elevated in the cerebrospinal fluid (CSF). The role of Natural Killer (NK) cells of the innate immune system in AD has largely been overlooked. In a murine model, depletion of NK cells augmented the accumulation of pathological α-syn.

View Article and Find Full Text PDF

Aim: SGLT2 inhibitors may be underused in older adults with type 2 diabetes due to concerns about safety and tolerability. This pooled analysis of the CANVAS Program and CREDENCE trial examined the efficacy and safety of canagliflozin according to age.

Methods: Pooled individual participant data from the CANVAS Program (n = 10 142) and CREDENCE trial (n = 4401) were analysed by baseline age (<65 years, 65 to <75 years, and ≥75 years).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!